These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Tarvasmäki T, Lassus J, Varpula M, Sionis A, Sund R, Køber L, Spinar J, Parissis J, Banaszewski M, Silva Cardoso J, Carubelli V, Di Somma S, Mebazaa A, Harjola VP, CardShock study investigators. Crit Care; 2016 Jul 04; 20(1):208. PubMed ID: 27374027 [Abstract] [Full Text] [Related]
15. Role of medical management of cardiogenic shock in the era of mechanical circulatory support. Blumer V, Marbach J, Veasey T, Kanwar M. Curr Opin Cardiol; 2022 May 01; 37(3):250-260. PubMed ID: 35612937 [Abstract] [Full Text] [Related]
17. Vasopressors and Inotropes in Sepsis. Stratton L, Berlin DA, Arbo JE. Emerg Med Clin North Am; 2017 Feb 01; 35(1):75-91. PubMed ID: 27908339 [Abstract] [Full Text] [Related]
18. Inotropes. Francis GS, Bartos JA, Adatya S. J Am Coll Cardiol; 2014 May 27; 63(20):2069-2078. PubMed ID: 24530672 [Abstract] [Full Text] [Related]
19. Vasopressors for acute myocardial infarction complicated by cardiogenic shock. Prondzinsky R, Hirsch K, Wachsmuth L, Buerke M, Unverzagt S. Med Klin Intensivmed Notfmed; 2019 Feb 27; 114(1):21-29. PubMed ID: 29204662 [Abstract] [Full Text] [Related]
20. Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database. Sasmita BR, Wang C, Xie S. Front Cardiovasc Med; 2023 Feb 27; 10():1300839. PubMed ID: 38094120 [Abstract] [Full Text] [Related] Page: [Next] [New Search]